1Y Close · As of Aug 26, 2026
CELL BIOTECH CO operates in the Pharmaceuticals sector.
Legal name: CELL BIOTECH CO ., LTD
In fiscal year 2025, CELL BIOTECH CO (049960) reported revenue of 53.1 billion KRW, up 6.4% from 49.9 billion KRW a year earlier.
Operating profit was 7.9 billion KRW and net income was 10.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 147.4 billion KRW, with a P/B of 1.12.
These figures can be verified in the DART filing (receipt no. 20260318001687).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 53.1B | 7.9B | 10.1B |
| 2024 | 49.9B | 6.8B | 15.1B |
| 2023 | 53.8B | 2.2B | 6.3B |
Recent Filings
Semi-Annual Report (2026.06)
Consolidated Operating (Preliminary) Earnings (Fair Disclosure)
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-07 | Consolidated Operating (Preliminary) Earnings (Fair Disclosure) |